Modulation of LAT1 (SLC7A5) transporter activity and stability by membrane cholesterol.

作者: David Dickens , George N. Chiduza , Gareth S. A. Wright , Munir Pirmohamed , Svetlana V. Antonyuk

DOI: 10.1038/SREP43580

关键词:

摘要: LAT1 (SLC7A5) is a transporter for both the uptake of large neutral amino acids and number pharmaceutical drugs. It expressed in numerous cell types including T-cells, cancer cells brain endothelial cells. However, mechanistic knowledge how it functions its interactions with lipids are unknown or limited due to inability obtaining stable purified protein sufficient quantities. Our data show that depleting cellular cholesterol reduced Vmax but not Km mediated model substrate into (L-DOPA). A soluble analogue was required purification chaperon CD98 (4F2hc,SLC3A2) this stabilised complex retained ability interact substrate. We propose interacts conserved regions have been shown bind cholesterol/CHS Drosophila melanogaster dopamine transporter. In conclusion, modulated by impacting on stability activity. This novel finding has implications other SLC7 family members additional eukaryotic transporters contain LeuT fold.

参考文章(50)
Lara Napolitano, Mariafrancesca Scalise, Michele Galluccio, Lorena Pochini, Leticia Maria Albanese, Cesare Indiveri, LAT1 is the transport competent unit of the LAT1/CD98 heterodimeric amino acid transporter The International Journal of Biochemistry & Cell Biology. ,vol. 67, pp. 25- 33 ,(2015) , 10.1016/J.BIOCEL.2015.08.004
Luca Mastroberardino, Benjamin Spindler, Rahel Pfeiffer, Patrick J. Skelly, Jan Loffing, Charles B. Shoemaker, François Verrey, Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family Nature. ,vol. 395, pp. 288- 291 ,(1998) , 10.1038/26246
Yu Zhao, Lin Wang, Jihong Pan, The role of L-type amino acid transporter 1 in human tumors Intractable & Rare Diseases Research. ,vol. 4, pp. 165- 169 ,(2015) , 10.5582/IRDR.2015.01024
Paul S. Miller, A. Radu Aricescu, Crystal structure of a human GABAA receptor Nature. ,vol. 512, pp. 270- 275 ,(2014) , 10.1038/NATURE13293
Aravind Penmatsa, Kevin H. Wang, Eric Gouaux, X-ray structure of dopamine transporter elucidates antidepressant mechanism Nature. ,vol. 503, pp. 85- 90 ,(2013) , 10.1038/NATURE12533
Jianyi Yang, Renxiang Yan, Ambrish Roy, Dong Xu, Jonathan Poisson, Yang Zhang, The I-TASSER Suite: protein structure and function prediction Nature Methods. ,vol. 12, pp. 7- 8 ,(2015) , 10.1038/NMETH.3213
Yoshikatsu Kanai, Hiroko Segawa, Ken-ichi Miyamoto, Hiroshi Uchino, Eiji Takeda, Hitoshi Endou, Expression Cloning and Characterization of a Transporter for Large Neutral Amino Acids Activated by the Heavy Chain of 4F2 Antigen (CD98) Journal of Biological Chemistry. ,vol. 273, pp. 23629- 23632 ,(1998) , 10.1074/JBC.273.37.23629
Linda V Sinclair, Julia Rolf, Elizabeth Emslie, Yun-Bo Shi, Peter M Taylor, Doreen A Cantrell, Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation Nature Immunology. ,vol. 14, pp. 500- 508 ,(2013) , 10.1038/NI.2556
Henriette Bjerregaard, Kasper Severinsen, Saida Said, Ove Wiborg, Steffen Sinning, A dualistic conformational response to substrate binding in the human serotonin transporter reveals a high affinity state for serotonin. Journal of Biological Chemistry. ,vol. 290, pp. 7747- 7755 ,(2015) , 10.1074/JBC.M114.573477
Marcel Meury, Meritxell Costa, Daniel Harder, Mirko Stauffer, Jean-Marc Jeckelmann, Béla Brühlmann, Albert Rosell, Hüseyin Ilgü, Karin Kovar, Manuel Palacín, Dimitrios Fotiadis, Detergent-induced stabilization and improved 3D map of the human heteromeric amino acid transporter 4F2hc-LAT2. PLOS ONE. ,vol. 9, ,(2014) , 10.1371/JOURNAL.PONE.0109882